Ligand Pharmaceuticals
LGND
#3601
Rank
โ‚น326.87 B
Marketcap
โ‚น16,608
Share price
-1.93%
Change (1 day)
57.11%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น60.81 Billion

According to Ligand Pharmaceuticals's latest financial reports the company has โ‚น60.81 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Ligand Pharmaceuticals - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น21.97 B55%
2023-12-31โ‚น14.17 B-19.13%
2022-12-31โ‚น17.53 B-30.95%
2021-12-31โ‚น25.38 B-15.57%
2020-12-31โ‚น30.07 B-60.58%
2019-12-31โ‚น76.29 B41%
2018-12-31โ‚น54.10 B320.22%
2017-12-31โ‚น12.87 B34.34%
2016-12-31โ‚น9.58 B-27.96%
2015-12-31โ‚น13.30 B25.46%
2014-12-31โ‚น10.60 B974.31%
2013-12-31โ‚น0.98 B45.62%
2012-12-31โ‚น0.67 B-24.8%
2011-12-31โ‚น0.90 B-11.36%
2010-12-31โ‚น1.01 B-58.82%
2009-12-31โ‚น2.46 B-36.3%
2008-12-31โ‚น3.87 B4.65%
2007-12-31โ‚น3.70 B-51.32%
2006-12-31โ‚น7.61 B94.57%
2005-12-31โ‚น3.91 B-19.7%
2004-12-31โ‚น4.87 B8.05%
2003-12-31โ‚น4.50 B46.35%
2002-12-31โ‚น3.08 B69.42%
2001-12-31โ‚น1.81 B64.66%
2000-12-31โ‚น1.10 B-46.18%
1999-12-31โ‚น2.05 B47.13%
1998-12-31โ‚น1.39 B-43.04%
1997-12-31โ‚น2.44 B95.71%
1996-12-31โ‚น1.25 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
โ‚น848.50 B 1,295.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚น5.04 B-91.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น399.26 B 556.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น1.636 T 2,590.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.346 T 2,113.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น890.59 B 1,364.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.482 T 2,337.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚น155.05 B 154.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น1.667 T 2,642.05%๐Ÿ‡บ๐Ÿ‡ธ USA